Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01

Journal of Hypertension

Volumn 22, Issue 8, 2004, Pages 1479-1485

  Cifková, Renata ^a   Škodová, Zdenka ^a   Lánská, Věra ^a   Adámková, Věra ^a   Novozámská, Eva ^a   Petržílková, Zdena ^a   Jozífová, Marie ^a   Plášková, Markéta ^a   Hejl, Zdeněk ^a   Palouš, Daniel ^a   Galovcová, Markéta ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Antihypertensive medication; Czech post MONICA study; Independent cross sectional surveys; Population random sample; WHO MONICA project

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CZECH REPUBLIC; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; RURAL AREA; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 3843054611     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000133737.77866.3e     Document Type: Article

References (40)

1. The Principal Investigators of the MONICA Project. WHO MONICA Project: geographic variation in mortality from cardiovascular diseases-baseline data on selected population characteristics and cardiovascular mortality. World Health Stat Q 1987; 40:171-184.
2. Uemura K, Pisa Z. Recent trends in cardiovascular disease mortality in 27 industrialized countries. World Health Stat Q 1985; 38:142-162.
3. Czech Health Statistics Yearbook 2000. Prague: Institute of Health Information and Statistics of the Czech Republic; 2001.
4. MacMahon S, Peto R, Cutler J, Collins R, Sortie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
5. Collins R, Peto R. Antihypertensive drug therapy: Effects on stroke and coronary artery disease. In: Swales JD (editor): Textbook of hypertension. Oxford: Blackwell Science; 1994, pp. 1156-1164.
6. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular disease mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18:1231-1248.
7. Škodová Z, Píša Z, Poledne R, Berka L, Cícha Z, Emrová R, et al. Decline of the cardiovascular mortality rate in the Czech Republic in 1984-1993 and its possible causes [in Czech, abstract in English]. Čas Lék čes 1997; 136:373-379.
8. Stamler J, Stamler R, Riedlieger WF, Algera G, Roberts RH. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) Program. 1973 through 1975. JAMA 1976; 235: 2299-2306.
9. Guidelines: Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-183.
10. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
11. The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
12. Chobanian AV, Bakris GI, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2572.
13. Horký K, Widimský J Sr, Cífková R, Widimský J Jr. Guidelines on diagnostic and therapeutic procedures in arterial hypertension (Version 2000) [in Czech]. Cor Vasa 2001; 43:K6-K15.
14. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeld D, Julius S, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762.
15. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960-1991. Hypertension 1995; 26:60-69.
16. Joffres MR, Ghardirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10:3097-3102.
17. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: from the health survey for England 1994. J Hypertens 1998; 26:747-752.
18. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1998; 96:308-315.
19. Darne B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989; 13: 392-400.
20. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160:1085-1089.
21. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100:354-360.
22. WHO MONICA Projects Principal Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 1988; 41:105-114.
23. Winkleby MA, Fortman SP, Barrett DC. Social class disparities in risk factors for disease: eight year prevalence patterns by level of education. Prev Med 1990; 19:1-12.
24. Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Int Med 1995; 155:701-709.
25. Kastarinen MJ, Salomaa VV, Vartiainen EA, Jousilahti PJ, Tuomilehto JO, Puska PM, Nissinen AM. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16:1379-1387.
26. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson JA, et al. Prospective study on nutritional factors, blood pressure, and hypertension among US women. Hypertension 1996; 27:1065-1072.
27. Sekavová H. Vývoj spotřeby potravin v domácnostech od roku 1989. Vývoj spotřeby H.H. Výživa 1999; 54:69-71.
28. Cifková R, Škodová Z, Lánská V, Poledne R, Adámková V, Novozámská E, et al. Longitudinal trends of total and HDL-cholesterol in a representative population sample of the Czech Republic [in Czech]. VnitŘ Lék 2000; 46:501-505.
29. Appel U, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al., for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336:1117-1124.
30. Hajjar I, Kotchen T. Regional variations of blood pressure in the United States are associated with regional variations in dietary intakes: the NHANES-III data. J Nutr 2003; 133:211-214.
31. Birkett NJ, Donner AP, Maynard MD. Assessing hypertension control in the community: the need for follow-up measurements to ensure clinical relevance. Can Med Assoc J 1987; 136:595-600.
32. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, et al. Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada and the United States. JAMA 2003; 289:2363-2369.
33. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19.
34. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000 JAMA 2003; 290:199-206.
35. Erdine S. How well is hypertension controlled in Europe? J Hypertens 2000; 18:1348-1350.
36. He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens 2003; 17: 455-457.
37. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002; 20:1461-1464.
38. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162:413-420.
39. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens 1999; 17(suppl 2): S7-S13.
40. Izzo JL, Levy D, Black HR. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35:1021-1024.